Abiogen Pharma is traditionally present in the “Bone Metabolism” market thanks to the marketing of drugs, conceived and developed in its Research Centre and now present throughout the world. This is why Abiogen Pharma is an Italian excellence in the bone pathologies therapy sector and an important reference point on the national scientific scene, thanks to an acknowledged leadership among sector specialists.